CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

A neoadjuvant clinical trial was previously conducted in patients with resectable colorectal cancer liver metastases (CRLM). At a median follow up of 28 months, 20/33 patients were dead of disease, 8 were alive with disease and 5 were alive with no evidence of disease. To shed further insight into b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: D'Alterio, Crescenzo, Nasti, Guglielmo, Polimeno, Marianeve, Ottaiano, Alessandro, Conson, Manuel, Circelli, Luisa, Botti, Giovanni, Scognamiglio, Giosuè, Santagata, Sara, De Divitiis, Chiara, Nappi, Anna, Napolitano, Maria, Tatangelo, Fabiana, Pacelli, Roberto, Izzo, Francesco, Vuttariello, Emilia, Botti, Gerardo, Scala, Stefania
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214751/
https://ncbi.nlm.nih.gov/pubmed/28123896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1254313
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia